DK1721976T3 - Modificeret promotor - Google Patents

Modificeret promotor

Info

Publication number
DK1721976T3
DK1721976T3 DK05720029T DK05720029T DK1721976T3 DK 1721976 T3 DK1721976 T3 DK 1721976T3 DK 05720029 T DK05720029 T DK 05720029T DK 05720029 T DK05720029 T DK 05720029T DK 1721976 T3 DK1721976 T3 DK 1721976T3
Authority
DK
Denmark
Prior art keywords
modified promoter
promoter
modified
Prior art date
Application number
DK05720029T
Other languages
English (en)
Inventor
Keiji Endo
Katsuya Ozaki
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of DK1721976T3 publication Critical patent/DK1721976T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05720029T 2004-03-05 2005-03-04 Modificeret promotor DK1721976T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004062853 2004-03-05
PCT/JP2005/003757 WO2005085441A1 (ja) 2004-03-05 2005-03-04 改変プロモーター

Publications (1)

Publication Number Publication Date
DK1721976T3 true DK1721976T3 (da) 2010-01-04

Family

ID=34918130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05720029T DK1721976T3 (da) 2004-03-05 2005-03-04 Modificeret promotor

Country Status (6)

Country Link
US (1) US8623631B2 (da)
EP (1) EP1721976B1 (da)
CN (1) CN1930291A (da)
DE (1) DE602005017469D1 (da)
DK (1) DK1721976T3 (da)
WO (1) WO2005085441A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4485341B2 (ja) * 2004-12-20 2010-06-23 花王株式会社 組換え微生物
JP5735775B2 (ja) 2009-10-21 2015-06-17 花王株式会社 改変プロモーター
WO2025264490A1 (en) * 2024-06-17 2025-12-26 Spark Therapeutics, Inc. Dna promoters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000210081A (ja) * 1999-01-21 2000-08-02 Kao Corp 耐熱性アルカリセルラ―ゼ遺伝子
JP4336082B2 (ja) * 2001-05-29 2009-09-30 花王株式会社 宿主微生物

Also Published As

Publication number Publication date
WO2005085441A1 (ja) 2005-09-15
US20080014608A1 (en) 2008-01-17
EP1721976B1 (en) 2009-11-04
US8623631B2 (en) 2014-01-07
EP1721976A4 (en) 2007-08-15
CN1930291A (zh) 2007-03-14
EP1721976A1 (en) 2006-11-15
DE602005017469D1 (de) 2009-12-17

Similar Documents

Publication Publication Date Title
NO2019035I1 (no) dakomitinib
NL300869I2 (nl) Olaratumab
DK2035563T3 (da) Patogen inducerbar syntetisk promotor
DE602005001452D1 (de) Polyurethane
DK1819670T3 (da) 12-Aryl-prostaglandinanaloger
DK1888550T3 (da) Apoptosepromotorer
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
DK1683933T3 (da) Betjeningsgreb
ATE392425T1 (de) Thiazolyl-dihydro-indazole
ATE459633T1 (de) Makrolide
DK2067854T3 (da) Kloningsvektorer
DE602005006889D1 (de) Fahrzeugluftausströmöffnungsanordnung
FI20045363A0 (fi) Nastarenkaan nasta
DE602005017469D1 (de) Modifizierter promotor
AT500198B1 (de) Ladewagen
ATE389633T1 (de) Omega-phenyloctanamide
SE0400321L (sv) Räddningsbåt
DE502005002052D1 (de) Transportvorrichtung
FR2871811B1 (fr) Endofucanase recombinante
EP1911459A4 (en) MEDIUM FOR PROMOTING LYMPHANGIOGENESIS
FI20041427L (fi) Pelastusvene
AT500249A3 (de) Scheibenegge
DK2333077T3 (da) Lager-induceret promotor
NO20050133D0 (no) Promoters
FI20051344A0 (fi) Kansirakenne